Effects of non-caloric ultrashort wave on the expression of CoQ10 and C1GALT1C1 in rats with cerebral ischemia reperfusion injury.
10.11817/j.issn.1672-7347.2020.180523
- Author:
Rao CHEN
1
;
Longkai PENG
1
;
Yihong YAN
1
;
Yongmei FAN
1
Author Information
1. Department of Rehabilitation, Second Xiangya Hospital, Central South University, Changsha 410011, China.
- Publication Type:Journal Article
- Keywords:
cerebral ischemia reperfusion injury;
coenzyme Q10;
ultrashort wave;
β 1,3-galactosyl transferase specific chaperone 1
- MeSH:
Animals;
Brain;
Brain Ischemia;
Molecular Chaperones;
Rats;
Rats, Sprague-Dawley;
Reperfusion Injury;
Ubiquinone;
analogs & derivatives
- From:
Journal of Central South University(Medical Sciences)
2020;45(1):24-34
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:To examine the changes of coenzyme Q10 (CoQ10) and β-galactosyl transferase specific chaperone 1 (C1GALT1C1) in brain of rats with ischemic injury at different time points and to explore the protective mechanism of ultrashort wave (USW) on ischemic brain injury.
METHODS:Fifty SD rats were randomly divided into 5 groups (=10 per group): a sham group (control group) and 4 experimental group (ischemia for 2 h). The 4 experimental groups were set as a model 1 d group, a USW 1 d group, a model 3 d group and a USW 3 d group, respectively. Five rats were randomly selected for 2,3,5-triphenyltetrazoliumchloride (TTC) staining in each experimental group, and the remaining 5 rats were subjected to Western blotting and real-time PCR. The percentage of cerebral infarction volume and the relative expression level of CoQ10 and C1GALT1C1 in the brain were examined and compared.
RESULTS:The infarct volume percentage after TTC staining was zero in the sham group. With the progress of disease and USW therapy, the infarct volume percentage was decreased in the experimental groups (all <0.05); Western blotting and real-time PCR showed that the relative expression level of CoQ10 in the sham group was the highest, while in the experimental groups, the content of CoQ10 showed a upward trend with the extension of disease and USW therapy, with significant difference (all <0.05). The relative expression level of C1GALT1C1 in the sham group was the lowest, but in the experimental groups, they showed a downward trend with the extension of disease and USW therapy, with significant difference (all <0.05).
CONCLUSIONS:Non-caloric USW therapy may upregulate the expression of CoQ10 to suppress the expression of C1GALT1C1 in rats, leading to alleviating cerebral ischemic reperfusion injury.
